Michele Cedrone

1.7k total citations
36 papers, 620 citations indexed

About

Michele Cedrone is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michele Cedrone has authored 36 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 21 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Michele Cedrone's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Michele Cedrone is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Michele Cedrone collaborates with scholars based in Italy, Switzerland and Belgium. Michele Cedrone's co-authors include Daniela Diverio, Roberta Riccioni, Ugo Testa, Robin Foà, Francesco Lo‐Coco, Gualtiero Mariani, Giuliana Alimena, Marco Mancini, C Peschle and Roberto Latagliata and has published in prestigious journals such as Blood, Cancer and Stem Cells.

In The Last Decade

Michele Cedrone

35 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Cedrone Italy 16 375 296 237 103 85 36 620
Russell R. Hoover United States 10 352 0.9× 286 1.0× 226 1.0× 51 0.5× 152 1.8× 18 831
Sarah Moore Australia 12 265 0.7× 175 0.6× 173 0.7× 74 0.7× 136 1.6× 32 563
Toshiya Yokozawa Japan 8 222 0.6× 281 0.9× 107 0.5× 108 1.0× 100 1.2× 17 528
Ali Tabarroki United States 10 448 1.2× 348 1.2× 225 0.9× 44 0.4× 60 0.7× 27 679
Sujiang Zhang China 13 368 1.0× 329 1.1× 223 0.9× 59 0.6× 149 1.8× 62 710
Fabio P S Santos United States 10 374 1.0× 171 0.6× 203 0.9× 90 0.9× 99 1.2× 16 520
Lidia De Felice Italy 13 485 1.3× 222 0.8× 161 0.7× 91 0.9× 141 1.7× 33 701
Marina Konopleva United States 13 532 1.4× 365 1.2× 197 0.8× 105 1.0× 156 1.8× 77 739
Fernanda Gutierrez‐Rodrigues United States 13 281 0.7× 194 0.7× 197 0.8× 43 0.4× 58 0.7× 44 708
Seiichiro Katagiri Japan 14 207 0.6× 199 0.7× 116 0.5× 111 1.1× 67 0.8× 59 498

Countries citing papers authored by Michele Cedrone

Since Specialization
Citations

This map shows the geographic impact of Michele Cedrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Cedrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Cedrone more than expected).

Fields of papers citing papers by Michele Cedrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Cedrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Cedrone. The network helps show where Michele Cedrone may publish in the future.

Co-authorship network of co-authors of Michele Cedrone

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Cedrone. A scholar is included among the top collaborators of Michele Cedrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Cedrone. Michele Cedrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ansuinelli, Michela, Cristina Papayannidis, Nicola Stefano Fracchiolla, et al.. (2025). Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study. Haematologica. 110(5). 1177–1181. 2 indexed citations
2.
Cambrin, Giovanna Rege, Matteo Leoncin, Marco Cerrano, et al.. (2023). Tyrosine Kinase Inhibitor (TKI) Discontinuation in Non-Allografted Ph+ Acute Lymphoblastic Leukemia Patients, a Campus ALL Real-Life Study. Blood. 142(Supplement 1). 2835–2835. 2 indexed citations
3.
Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations
4.
Breccia, Massimo, Alessandro Andriani, Marco Montanaro, et al.. (2016). Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN. Annals of Hematology. 96(3). 387–391. 13 indexed citations
5.
Latagliata, Roberto, Ambra Di Veroli, Pasquale Niscola, et al.. (2015). Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. European Journal Of Haematology. 96(6). 643–649. 16 indexed citations
6.
Latagliata, Roberto, Pasquale Niscola, Fabrizio Ciccone, et al.. (2013). Deferasirox In The Treatment Of Iron Overload During Myeloproliferative Neoplasms (MPN). Blood. 122(21). 1594–1594. 1 indexed citations
7.
8.
Riccioni, Roberta, Daniela Diverio, Gualtiero Mariani, et al.. (2007). M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib‐mediated apoptosis. British Journal of Haematology. 139(2). 194–205. 32 indexed citations
9.
Riccioni, Roberta, Alessia Calzolari, Mauro Biffoni, et al.. (2006). Podocalyxin is expressed in normal and leukemic monocytes. Blood Cells Molecules and Diseases. 37(3). 218–225. 20 indexed citations
10.
Mancini, Marco, Michele Cedrone, Daniela Diverio, et al.. (2000). Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients. Leukemia. 14(3). 364–368. 19 indexed citations
11.
Girmenia, Corrado, Claudio Cartoni, Michele Cedrone, et al.. (1997). Management of infective complications in patients with advanced hematologic malignancies in home care. Leukemia. 11(11). 1807–1812. 26 indexed citations
12.
Alimena, Giuliana, Mario Lazzarino, Enrica Morra, et al.. (1996). Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon.. IRIS Research product catalog (Sapienza University of Rome). 10(4). 615–8. 5 indexed citations
13.
Mancini, Marco, Mauro Nanni, Michele Cedrone, et al.. (1995). Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. British Journal of Haematology. 91(4). 878–884. 31 indexed citations
14.
Testi, Anna Maria, Maria Luisa Moleti, Marco Vignetti, et al.. (1994). Myelodysplastic syndromes in childhood: description of seven cases. Annals of Hematology. 68(5). 241–245. 3 indexed citations
15.
Annino, Luciana, Michele Cedrone, Fiorina Giona, et al.. (1994). Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period.. PubMed. 8(4). 664–7. 30 indexed citations
16.
Alimena, Giuliana, Giovanna Meloni, Francesco Lo‐Coco, et al.. (1993). Management of Chronic Myeloid Leukemia in Chronic Phase with Autologous Stem Cell Transplantation and Alpha-2 Interferon: Cytogenetic and Clinical Results. Leukemia & lymphoma. 11(sup1). 281–291. 4 indexed citations
17.
Mancini, Marco, et al.. (1993). Trisomy 14 in hematologic diseases. Cancer Genetics and Cytogenetics. 66(1). 39–42. 17 indexed citations
18.
Montefusco, Enrico, G. Alimena, Maria Antonietta Aloe Spiriti, et al.. (1992). Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome. Annals of Hematology. 65(1). 17–21. 13 indexed citations
19.
Cedrone, Michele, et al.. (1991). Reciprocal translocation involving 3q21 in an unusual myeloproliferative disorder with myelodysplastic features and prominent dysmegakaryopoiesis. Cancer Genetics and Cytogenetics. 51(1). 73–78. 3 indexed citations
20.
Alimena, Giuliana, Enrico Montefusco, Marco Mancini, et al.. (1989). Prolonged effect of alpha‐interferon after discontinuance of treatment in chronic myelogenous leukemia patients. European Journal Of Haematology. 43(2). 108–111. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell R. Hoover Breakdown of academic impact, for papers by Sarah Moore Breakdown of academic impact, for papers by Toshiya Yokozawa Breakdown of academic impact, for papers by Ali Tabarroki Breakdown of academic impact, for papers by Sujiang Zhang Breakdown of academic impact, for papers by Fabio P S Santos Breakdown of academic impact, for papers by Lidia De Felice Breakdown of academic impact, for papers by Marina Konopleva Breakdown of academic impact, for papers by Fernanda Gutierrez‐Rodrigues Breakdown of academic impact, for papers by Seiichiro Katagiri
Rankless by CCL
2026